High-density lipoprotein subfractions and carotid plaque: The Northern Manhattan Study

Atherosclerosis

Volumn 237, Issue 1, 2014, Pages 163-168

  Tiozzo, Eduard ^a   Gardener, Hannah ^a   Hudson, Barry I ^b   Dong, Chuanhui ^a   Della Morte, David ^a,c,d   Crisby, Milita ^e   Goldberg, Ronald B ^b   Elkind, Mitchell S V ^f   Cheung, Ying Kuen ^g   Wright, Clinton B ^a   Sacco, Ralph L ^a   Rundek, Tatjana ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Karolinska Institute Department of Neurobiology Care Sciences and Society ^*  (United States)

^g Diabetes Research Institute and Lipid Disorder Clinic University of Miami ^*  (United States)

Author keywords

Carotid plaque; High density lipoprotein; High density lipoprotein subfractions

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; VERY ELDERLY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY; COHORT ANALYSIS; ETHNOLOGY; PATHOLOGY; REGRESSION ANALYSIS; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL, HDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HISPANIC AMERICANS; HUMANS; LIPOPROTEINS, HDL2; LIPOPROTEINS, HDL3; MALE; MIDDLE AGED; NEW YORK; PLAQUE, ATHEROSCLEROTIC; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84907790125     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.09.002     Document Type: Article

References (38)

1. Sacco R.L., Benson R.T., Kargman D.E., Boden-Albala B., Tuck C., Lin I.F., et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001 June 6, 285(21):2729-2735.
2. Maron D.J. The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am J Cardiol 2000 December 21, 86(12A):11L-14L.
3. Amarenco P., Labreuche J., Touboul P.J. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis 2008 February, 196(2):489-496.
4. Bots M.L., Visseren F.L., Evans G.W., Riley W.A., Revkin J.H., Tegeler C.H., et al. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet 2007 July 14, 370(9582):153-160.
5. Barter P., Kastelein J., Nunn A., Hobbs R. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 2003 June, 168(2):195-211.
6. Voight B.F., Peloso G.M., Orho-Melander M., Frikke-Schmidt R., Barbalic M., Jensen M.K., et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012 August 11, 380(9841):572-580.
7. Superko H.R., Pendyala L., Williams P.T., Momary K.M., King S.B., Garrett B.C. High-density lipoprotein subclasses and their relationship to cardiovascular disease. JClin Lipidol 2012 November, 6(6):496-523.
8. Akinkuolie A.O., Paynter N.P., Padmanabhan L., Mora S. High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease. Circ Cardiovasc Qual Outcomes 2014 January 1, 7(1):55-63.
9. Della-Morte D., Guadagni F., Palmirotta R., Testa G., Caso V., Paciaroni M., et al. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics 2012, 13(5):595-613.
10. Johansson J., Carlson L.A., Landou C., Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991 January, 11(1):174-182.
11. Hamsten A., Walldius G., Szamosi A., Dahlen G., de Faire U. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 1986 June, 73(6):1097-1110.
12. Xu Y.X., Fu M.D., Xu Y.H., Yang L.C. Relationship between the contents of serum HDL subclasses and the extent of coronary stenosis in coronary heart disease patients. Sichuan Da Xue Xue Bao Yi Xue Ban 2004 July, 35(4):500-502.
13. Shuhei N., Soderlund S., Jauhiainen M., Taskinen M.R. Effect of HDL composition and particle size on the resistance of HDL to the oxidation. Lipids Health Dis 2010, 9:104.
14. Kontush A., Chantepie S., Chapman M.J. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003 October 1, 23(10):1881-1888.
15. Phan B.A., Chu B., Polissar N., Hatsukami T.S., Yuan C., Zhao X.Q. Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging. Int J Cardiovasc Imaging 2007 June, 23(3):337-342.
16. Sacco R.L., Gan R., Boden-Albala B., Lin I.F., Kargman D.E., Hauser W.A., et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 1998 February, 29(2):380-387.
17. Wallman K.K., Hodgdon J. Race and ethnic standards for Federal statistics and administrative reporting 1977, 77-110. Stat Report, 450-4.
18. Sacco R.L., Elkind M., Lin I.F., Kargman D.E., Hauser W.A., Shea S., et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999 January 6, 281(1):53-60.
19. Hirano T., Nohtomi K., Koba S., Muroi A., Ito Y. Asimple and precise method for measuring HDL-cholesterol subfractions by a single precipitation followed by homogenous HDL-cholesterol assay. JLipid Res 2008 May, 49(5):1130-1136.
20. Rundek T., Blanton S.H., Bartels S., Dong C., Raval A., Demmer R.T., et al. Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke 2013 May 23, 44:2101-2108.
21. Kuo F., Gardener H., Dong C., Cabral D., Della-Morte D., Blanton S.H., et al. Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke 2012 July, 43(7):1755-1760.
22. Rundek T., Arif H., Boden-Albala B., Elkind M.S., Paik M.C., Sacco R.L. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008 April 1, 70(14):1200-1207.
23. Vergeer M., Holleboom A.G., Kastelein J.J., Kuivenhoven J.A. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?. JLipid Res 2010 August, 51(8):2058-2073.
24. Castelli W.P. Epidemiology of coronary heart disease: the Framingham study. Am J Med 1984 February 27, 76(2A):4-12.
25. Touboul P.J., Labreuche J., Bruckert E., Schargrodsky H., Prati P., Tosetto A., et al. HDL-C, triglycerides and carotid IMT: a meta-analysis of 21,000 patients with automated edge detection IMT measurement. Atherosclerosis 2014 January, 232(1):65-71.
26. Warnick G.R. High-density lipoproteins: the neglected stepchildren whose importance as a risk factor continues to be defined. Clin Chem 2008 May, 54(5):923-924.
27. Navab M., Anantharamaiah G.M., Fogelman A.M. The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 2005 May, 15(4):158-161.
28. Rosenson R.S., Brewer H.B., Chapman M.J., Fazio S., Hussain M.M., Kontush A., et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem 2011 March, 57(3):392-410.
29. Ashby D.T., Rye K.A., Clay M.A., Vadas M.A., Gamble J.R., Barter P.J. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler Thromb Vasc Biol 1998 September, 18(9):1450-1455.
30. Williams P.T. Low high-density lipoprotein 3 reduces the odds of men surviving to age 85 during 53-year follow-up. JAm Geriatr Soc 2012 March, 60(3):430-436.
31. Fagot-Campagna A., Knowler W.C., Narayan K.M., Hanson R.L., Saaddine J., Howard B.V. HDL cholesterol subfractions and risk of developing type 2 diabetes among Pima Indians. Diabetes Care 1999 February, 22(2):271-274.
32. Kherkeulidze P., Johansson J., Carlson L.A. High density lipoprotein particle size distribution in cord blood. Acta Paediatr Scand 1991 August, 80(8-9):770-779.
33. Nissen S.E., Tardif J.C., Nicholls S.J., Revkin J.H., Shear C.L., Tuggan W.T., et al. Effect of torcetrapib on the progression of coronary atherosclerosis. NEngl J Med 2007 March 29, 356(13):1304-1316.
34. Barter P.J., Caulfield M., Eriksson M., Grundy S.M., Kastelein J.J.P., Komajda M., et al. Effects of torcetrapib in patients at high risk for coronary events. NEngl J Med 2007 November 22, 357(21):2109-2122.
35. Bellanger N., Julia Z., Villard E.F., El Khoury P., Duchene E., Chapman M.J., et al. Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy. Atherosclerosis 2012 March, 221(1):160-168.
36. Barnett P.A., Spence J.D., Manuck S.B., Jennings J.R. Psychological stress and the progression of carotid artery disease. JHypertens 1997 January, 15(1):49-55.
37. Johnsen S.H., Mathiesen E.B. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 2009 January, 11(1):21-27.
38. Tsai L.Y., Peng M.R., Tsai S.M., Hsieh S.F. The determination of high density lipoprotein cholesterol separated by electrophoresis and sodium phosphotungstate/Mg2+ precipitation: a physical evaluation. Gaoxiong Yi Xue Ke Xue Za Zhi 1989 September, 5(9):498-504.